OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 90 filers reported holding OLEMA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,904,424 | -75.3% | 235,176 | -82.0% | 0.48% | -70.7% |
| Q2 2023 | $11,778,118 | +68.7% | 1,304,332 | -35.2% | 1.62% | +79.8% |
| Q1 2023 | $6,981,130 | +40.7% | 2,011,853 | -0.7% | 0.90% | +18.4% |
| Q4 2022 | $4,961,823 | +28.4% | 2,025,234 | +44.7% | 0.76% | -6.5% |
| Q3 2022 | $3,863,000 | +281.0% | 1,399,633 | +461.6% | 0.81% | +214.3% |
| Q2 2022 | $1,014,000 | -15.2% | 249,229 | -11.3% | 0.26% | -33.2% |
| Q1 2022 | $1,196,000 | -56.5% | 280,827 | -4.4% | 0.39% | -73.6% |
| Q4 2021 | $2,750,000 | – | 293,799 | – | 1.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 7,803,600 | $96,374,460 | 6.54% |
| Logos Global Management LP | 3,743,875 | $46,236,856 | 6.17% |
| MPM BioImpact LLC | 1,857,681 | $22,942,360 | 6.12% |
| Cormorant Asset Management, LP | 4,504,764 | $55,633,835 | 3.24% |
| BVF INC/IL | 9,135,893 | $112,828,279 | 3.04% |
| Vivo Capital, LLC | 1,873,704 | $23,140,244 | 2.54% |
| Altium Capital Management LP | 335,000 | $4,137,250 | 2.16% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 407,801 | $5,036,342 | 1.53% |
| HighVista Strategies LLC | 247,880 | $3,061,318 | 1.42% |
| ACUTA CAPITAL PARTNERS, LLC | 153,007 | $1,889,636 | 1.27% |